JACLYN SULLIVAN: Open Payments
NPI 1730644873 · EMERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 34 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $444 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $178 |
| PFIZER INC. | 5 | $85 |
| Madrigal Pharmaceuticals | 4 | $74 |
| QOL Medical, LLC | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| GENZYME CORPORATION | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| KYOWA KIRIN, INC. | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, VELSIPITY, REZDIFFRA, Sucraid, ENTYVIO, CRYSVITA, Bimzelx.
Industry payments across NJ — which companies pay providers there.
